Explore more publications!

Tech Journal of Colorado: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.

Press releases published on November 3, 2025

Pyxis Oncology to Participate in Upcoming Investor Conferences
Mobile Infrastructure Announces Timing of Third Quarter 2025 Earnings Release and Conference Call
Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®
BBOT to Participate in the Jefferies Global Healthcare Conference in London
iMDx to Release Third Quarter 2025 Results on November 10 and Attend Stephens Annual Investment Conference the Following Week
Bitterroot Bio to Present Anti-CD47 Research at American Heart Association Annual Scientific Session 2025
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November
Tactile Systems Technology, Inc. Reports Third Quarter 2025 Financial Results
EverQuote Announces Third Quarter 2025 Financial Results
Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution
ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TELA Bio Appoints William Plovanic to Board of Directors
NurExone Accepted into ARMI’s BioFab Startup Lab Strengthening U.S Position in Regenerative Manufacturing
FibroGen to Report Third Quarter 2025 Financial Results
Kura Oncology Receives Second $30 Million Development Milestone Payment in AML Menin Inhibitor Program With Kyowa Kirin
Mdxhealth to Release Third Quarter 2025 Financial Results on November 12
Galapagos zal nieuwe gegevens presenteren over celtherapieprogramma tijdens ASH 2025
Galapagos to Present New Data from Cell Therapy Program at ASH 2025
Rapid7 Expands Partnership with Microsoft to Advance Modern Detection and Response

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions